ADVERSE REACTIONS TO THE MAIN ANTITUBERCULOUS AGENTS

  • Ieva Gaudiešiūtė
  • Greta Musteikienė
  • Skaidrius Miliauskas
  • Marius Žemaitis
DOI: https://doi.org/10.37499/PIA.228
Keywords: drug-susceptible tuberculosis, isoniazid, rifampicin, ethambutol, pyrazinamide

Abstract

Despite the fact, that the first line antituberculous agents, created a few decades ago, are efficient and able to cure tuberculosis, their side effects that might manifest may vary from the clinically insignificant to the life-threatening.

Author Biographies

Ieva Gaudiešiūtė

Faculty of Medicine, Medical Academy, Lithuanian University of Health Sciences

Greta Musteikienė

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences

Skaidrius Miliauskas

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences

Marius Žemaitis

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences

How to Cite
1.
Gaudiešiūtė I, Musteikienė G, Miliauskas S, Žemaitis M. ADVERSE REACTIONS TO THE MAIN ANTITUBERCULOUS AGENTS [Internet]. PIA 2017 May;1(1):22-24.[cited 2024 Nov. 25 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/228
Issue
Vol 1 No 1 (2017): Pulmonology and Allergology
Section
Pulmonology and allergology